144 related articles for article (PubMed ID: 8831731)
1. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells.
Kargman S; Wong E; Greig GM; Falgueyret JP; Cromlish W; Ethier D; Yergey JA; Riendeau D; Evans JF; Kennedy B; Tagari P; Francis DA; O'Neill GP
Biochem Pharmacol; 1996 Oct; 52(7):1113-25. PubMed ID: 8831731
[TBL] [Abstract][Full Text] [Related]
2. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
4. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells.
Kirtikara K; Swangkul S; Ballou LR
Inflamm Res; 2001 Jun; 50(6):327-32. PubMed ID: 11475335
[TBL] [Abstract][Full Text] [Related]
5. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
Jaradat MS; Wongsud B; Phornchirasilp S; Rangwala SM; Shams G; Sutton M; Romstedt KJ; Noonan DJ; Feller DR
Biochem Pharmacol; 2001 Dec; 62(12):1587-95. PubMed ID: 11755111
[TBL] [Abstract][Full Text] [Related]
7. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors.
Rieke CJ; Mulichak AM; Garavito RM; Smith WL
J Biol Chem; 1999 Jun; 274(24):17109-14. PubMed ID: 10358065
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
Laneuville O; Breuer DK; Dewitt DL; Hla T; Funk CD; Smith WL
J Pharmacol Exp Ther; 1994 Nov; 271(2):927-34. PubMed ID: 7965814
[TBL] [Abstract][Full Text] [Related]
9. Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells.
Wong E; DeLuca C; Boily C; Charleson S; Cromlish W; Denis D; Kargman S; Kennedy BP; Ouellet M; Skorey K; O'Neill GP; Vickers PJ; Riendeau D
Inflamm Res; 1997 Feb; 46(2):51-9. PubMed ID: 9085144
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
12. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
Rosenstock M; Danon A; Rimon G
Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid.
O'Neill GP; Mancini JA; Kargman S; Yergey J; Kwan MY; Falgueyret JP; Abramovitz M; Kennedy BP; Ouellet M; Cromlish W
Mol Pharmacol; 1994 Feb; 45(2):245-54. PubMed ID: 8114674
[TBL] [Abstract][Full Text] [Related]
15. PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs.
DeWitt DL; Meade EA; Smith WL
Am J Med; 1993 Aug; 95(2A):40S-44S. PubMed ID: 8357002
[TBL] [Abstract][Full Text] [Related]
16. Altered sensitivity of aspirin-acetylated prostaglandin G/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs.
Mancini JA; Vickers PJ; O'Neill GP; Boily C; Falgueyret JP; Riendeau D
Mol Pharmacol; 1997 Jan; 51(1):52-60. PubMed ID: 9016346
[TBL] [Abstract][Full Text] [Related]
17. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety.
Mancini JA; Riendeau D; Falgueyret JP; Vickers PJ; O'Neill GP
J Biol Chem; 1995 Dec; 270(49):29372-7. PubMed ID: 7493972
[TBL] [Abstract][Full Text] [Related]
18. Delayed release of prostaglandins from arachidonic acid and kinetic changes in prostaglandin H synthase activity on the induction of prostaglandin H synthase-2 after lipopolysaccharide-treatment of RAW264.7 macrophage-like cells.
Tanaka Y; Takahashi M; Kawaguchi M; Amano F
Biol Pharm Bull; 1997 Apr; 20(4):322-6. PubMed ID: 9145202
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.
Rosenstock M; Danon A; Rubin M; Rimon G
Eur J Pharmacol; 2001 Jan; 412(1):101-8. PubMed ID: 11166741
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid.
Bhattacharyya DK; Lecomte M; Dunn J; Morgans DJ; Smith WL
Arch Biochem Biophys; 1995 Feb; 317(1):19-24. PubMed ID: 7872783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
